Anna Kowalczuk

A seasoned manager with nearly 20 years of experience in the pharmaceutical industry.

Graduate of the Medical University of Warsaw and postgraduate studies in management at the University of Warsaw, where she also completed the Executive Master of Business Administration (EMBA) program.

Research intern at the US National Center for Natural Products Research and the University of Mississippi in 2011-2012.Director of the National Medicines Institute in 2017-2022.

Author of scientific articles in domestic and foreign industry journals and postgraduate study programs. Panelist at scientific conferences. Lecturer.

Member of advisory teams and scientific councils.

• Committee for Medicinal Products at the President of URPLWMiPB;
• Team for Active Pharmaceutical Ingredients at the Ministry of Development, Labor, and Technology;
• Scientific Council of the Institute of Physiology and Pathology of Hearing;
• Scientific Council of the National Institute of Geriatrics, Rheumatology, and Rehabilitation;
• European Pharmacopoeia Commission Herbal drugs and Herbal drug products;
• Advisory groups of the European Directorate for the Quality of Medicines in Strasbourg: EDQM Advisory Group CAP and EDQM Communication Working Group.
• Team for Supporting Digitization in Healthcare,
• National Cardiology Council.

She has been Deputy President of the Agency for Health Technology Assessment and Tariff System since 2 September 2024.